Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.

European journal of nuclear medicine and molecular imaging·2026
Same author

Pain in Functional Motor Disorders: Clinical Correlates From the Italian Registry.

European journal of neurology·2026
Same author

Trazodone for management of depression in Parkinson's disease: expert opinion and proposal for a treatment algorithm.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Wearable Inertial Sensor Analysis of Turning Performance Reveals Motor Reserve Effects in Drug-Naïve Parkinson's Disease.

Sensors (Basel, Switzerland)·2026
Same author

Spatio-temporal gait signatures across prodromal and early Parkinson's disease in two independent cohorts.

Scientific reports·2026
Same author

LIFETIME JEM-DERIVED OCCUPATIONAL EXPOSURE BURDEN AND ODDS OF PARKINSON'S DISEASE AND PARKINSONISM IN A MATCHED CASE-CONTROL STUDY.

medRxiv : the preprint server for health sciences·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Sebastian Palmqvist1, Noëlle Warmenhoven1, Federica Anastasi2

  • 1Lund University, Lund, Sweden.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

针对阿尔茨海默病 (AD) 的新型血液检测显示,在诊断AD病理方面,其准确性很高. 自动化和质谱测试适合临床使用,尽管有些可能需要采用两种切断方法.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经学 神经学
  • 生物标志物发现发现
  • 临床诊断 临床诊断 临床诊断

背景情况:

  • 针对阿尔茨海默病 (AD) 的新兴基于血液的生物标志物需要在临床实践中进行验证.
  • 关于新型AD诊断试验的执行,存在重大知识差距.

研究的目的:

  • 评估完全自动化的免疫测试和基于质谱的血光217 (p-tau217),Aβ42和Aβ40.0的测试.
  • 评估这些生物标志物的诊断性能在不同的临床队列.

主要方法:

  • 包括来自四个二级护理队伍和一个初级护理队伍的1,767名具有认知症状的参与者.
  • 使用Lumipulse免疫测试 (Fujirebio) 测量了血p-tau217和Aβ42.
  • 使用质谱法 (PrecivityAD2;C2N诊断) 测量了%p-tau217和Aβ42/40的比率.
  • 通过大脑脊髓液Aβ42/p-tau181比率定义为AD病理的主要结局.

主要成果:

  • 血p-tau217 (Lumipulse) 在检测AD病理方面显示出高精度 (AUC 0.93-0.96).
  • 在二级护理中的准确率为89-91%,正预测值 (PPV) 为89-95%,负预测值 (NPV) 为77-90%.
  • 初级保健准确率为85% (PPV 82%,NPV 88%),性能不受并发病或APOE基因型的影响.
  • 基于质谱的%p-tau217显示了类似的二级护理准确度和更高的初级护理准确度,不受年龄的影响.

结论:

  • 自动化和质谱测试都显示出在阿尔茨海默病诊断中临床实施的前景.
  • 对于特定的环境和子群体,可能需要采用两种切断方法,特别是在自动化测试中.
  • 进一步的研究将探索临床医生的态度,临床实用性,并与CSF生物标志物和粉样蛋白PET成像进行比较.